Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

492
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
492
Survival Curves01:18

Survival Curves

931
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
931
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

955
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
955
Survival Tree01:19

Survival Tree

499
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
499

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics investigation of per- and polyfluoroalkyl substances in lung adenocarcinoma: comprehensive network toxicology, machine learning and molecular docking experiments.

Molecular diversity·2026
Same author

Predictive Value of Incorporating Principal Diagnosis into CGA for Short-Term Functional Recovery in an ACE Unit: A Retrospective Study.

Clinical interventions in aging·2026
Same author

Combined application of the modified early warning score and the modified hematoma expansion prediction score for predicting hematoma expansion in intracerebral hemorrhage.

Scientific reports·2026
Same author

A drug-free, engineered hybrid exosome platform alleviates atherosclerosis via inflammation modulation and phenotype remodeling.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Molecular mechanism of aloe emodin in combating nasopharyngeal carcinoma revealed through network pharmacology, molecular docking, and in vitro experiments.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Transcriptomic and proteomic analysis of osteogenesis imperfecta disease-specific induced pluripotent stem cells.

BMC medical genomics·2026

Related Experiment Video

Updated: May 1, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Semiparametric transformation models for semicompeting survival data.

Huazhen Lin1, Ling Zhou1, Chunhong Li2

  • 1Center of Statistical Research, School of Statistics, Southwestern University of Finance and Economics, Chengdu, Sichuan, China.

Biometrics
|April 23, 2014
PubMed
Summary

This study introduces a new statistical model for analyzing semicompeting risks in clinical trials, improving regression analysis and surrogacy measures for disease progression and death.

Keywords:
Semicompeting risk dataSemiparametric linear transformation modelSurrogate endpoints

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Related Experiment Videos

Last Updated: May 1, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Survival Analysis

Background:

  • Semicompeting risk data, such as time to disease progression and time to death, are frequent in clinical trials.
  • Existing statistical tools for analyzing such data are limited.
  • Accurate analysis is crucial for understanding treatment effects and patient outcomes.

Purpose of the Study:

  • To propose a novel semiparametric transformation model for semicompeting risk data.
  • To enhance the simultaneous estimation of regression and association parameters.
  • To enable direct calculation of surrogacy measures, including mediation and ratio of treatment effects.

Main Methods:

  • Development of a semiparametric transformation model.
  • Simultaneous estimation of regression coefficients and association parameters.
  • Proposal of an estimation procedure for statistical inference.

Main Results:

  • The proposed estimator is shown to be consistent and asymptotically normal.
  • The method allows for direct computation of surrogacy measures.
  • Simulations confirm the validity and utility of the proposed method.

Conclusions:

  • The novel semiparametric transformation model effectively addresses limitations in analyzing semicompeting risk data.
  • The method provides simultaneous estimation and direct surrogacy measures, advancing clinical trial analysis.
  • Application to a multiple myeloma trial demonstrates its practical utility in assessing biomarkers for semicompeting outcomes.